N ormal pregnancy (Norm-Preg) is associated with increased plasma volume and cardiac output, decreased vascular resistance, and slight or no change in blood pressure (BP).
N ormal pregnancy (Norm-Preg) is associated with increased plasma volume and cardiac output, decreased vascular resistance, and slight or no change in blood pressure (BP). 1 Preeclampsia is a major disorder affecting ≈5% to 8% of pregnancies in the United States and 8 million pregnancies worldwide. 2 Preeclampsia is manifested as maternal hypertension 3, 4 and, if untreated, could lead to eclampsia with severe hypertension and seizures. Preeclampsia may be associated with intrauterine growth restriction and could lead to in utero programming of cardiovascular, renal, and metabolic disorders and adult-onset hypertension and diabetes mellitus. 5 Although preeclampsia poses serious consequences to the health of mother and fetus, the mechanisms involved are unclear. Placental ischemia could be an initiating event 4 leading to release of various bioactive factors in the maternal circulation including cytokines, anti-angiogenic factors, angiotensin receptor type-1 agonistic auto-antibody, reactive oxygen species, and hypoxia-inducible factor. [6] [7] [8] These circulating factors are thought to cause generalized endotheliosis in the peripheral, glomerular, and cerebral vessels leading to some of the hallmarks of preeclampsia/eclampsia, namely hypertension, proteinuria, and seizures, respectively 9 ; however, the central endothelial cell target involved is unclear.
One of the major factors released by endothelium is endothelin-1 (ET-1). ET-1 is a potent vasoconstrictor in some forms of hypertension including hypertensive pregnancy (HTNPreg). 3, 10 Also, plasma ET-1 levels are increased in preeclamptic women. 3, 11 Because of the difficulty to perform mechanistic studies in pregnant women, we and others have utilized animal models of HTN-Preg such as the rat model of placental ischemia produced by reduction of uteroplacental perfusion pressure (RUPP). 6, 8, 12 RUPP rats mimic some of the features of preeclampsia in women, including hypertension, endothelial Abstract-Preeclampsia is a pregnancy-related disorder characterized by hypertension with an unclear mechanism. Studies have shown endothelial dysfunction and increased endothelin-1 (ET-1) levels in hypertensive pregnancy (HTN-Preg).
ET-1 activates endothelin receptor type-A in vascular smooth muscle to induce vasoconstriction, but the role of vasodilator endothelial endothelin receptor type-B (ET B R) in the changes in blood pressure (BP) and vascular function in HTN-Preg is unclear. To test whether downregulation of endothelial ET B R expression/activity plays a role in HTN-Preg, BP was measured in normal pregnancy (Norm-Preg) rats and rat model of HTN-Preg produced by reduction of uteroplacental perfusion pressure (RUPP), and mesenteric microvessels were isolated for measuring diameter, [Ca 2+ ] i , and endothelin receptor type-A and ET B R levels. BP, ET-1-and potassium chloride-induced vasoconstriction, and [Ca 2+ ] i were greater in RUPP than in NormPreg rats. Endothelium removal or microvessel treatment with ET B R antagonist BQ-788 enhanced ET-1 vasoconstriction and [Ca 2+ ] i in Norm-Preg, but not RUPP, suggesting reduced vasodilator ET B R in HTN-Preg. The ET-1+endothelin receptor type-A antagonist BQ-123 and the ET B R agonists sarafotoxin 6c and IRL-1620 caused less vasorelaxation and nitrate/ nitrite production in RUPP than in Norm-Preg. The nitric oxide synthase inhibitor Nω-nitro-L-arginine methyl ester reduced sarafotoxin 6c-and IRL-1620-induced relaxation in Norm-Preg but not in RUPP, supporting that ET B R-mediated nitric oxide pathway is compromised in RUPP. Reverse transcription polymerase chain reaction, Western blots, and immunohistochemistry revealed reduced endothelial ET B R expression in RUPP. Infusion of BQ-788 increased BP in Norm-Preg, and infusion of IRL-1620 reduced BP and ET-1 vasoconstriction and [Ca dysfunction, and increased vascular reactivity. 3, 4, 12 RUPP rats also exhibit increased expression of preproET mRNA in the renal medulla and cortex. 13 ET-1 activates endothelin receptor type-A (ET A R) and type-B (ET B R). ET A R is mainly expressed in vascular smooth muscle (VSM) to induce vasoconstriction, whereas ET B R is predominately expressed in endothelial cells to induce the release of vasodilator substances, 14, 15 and also plays a role in ET-1 clearance. 16 Although a role of ET-1 and its vasoconstrictor ET A R in modulation of cardiovascular-renal function during HTN-Preg has been suggested, 3, [17] [18] [19] the role of vasodilator endothelial ET B R during Norm-Preg and HTNPreg, and the post-ET B R mediators involved are less clear.
We have recently shown that ET-1-induced vasoconstriction is reduced and that ET B R expression and ET B R-mediated vasodilation are enhanced in microvessels of Norm-Preg rats. 20 The present study was designed to test the hypothesis that downregulation of endothelial ET B R is an important mechanism in HTN-Preg. We used mesenteric microvessels from RUPP and Norm-Preg rats to determine whether (1) the increased BP in HTN-Preg reflects increased ET-1-induced constriction and decreased ET B R-mediated relaxation via the nitric oxide (NO), prostacyclin, or endothelium-derived hyperpolarizing factor (EDHF) pathway, (2) HTN-Preg is associated with reduced endothelial ET B R expression/activity, and (3) 
Methods
See details in Methods in the online-only Data Supplement.
Animals
Time-pregnant (day 13) Sprague-Dawley rats were either shamoperated (Norm-Preg) or underwent surgical RUPP by placing a silver clip (0.203 mm ID) on the lower abdominal aorta and 2 clips (0.1 mm ID) on uterine branches of the ovarian artery. 8, 12 To test the role of ET B R in HTN-Preg, other pregnant rats were infused with the ET B R antagonist BQ-788 100 μg/kg per day subcutaneously for 5 days using osmotic minipump. Also, some RUPP rats were infused with the ET B R agonist IRL-1620 100 μg/kg per day subcutaneously for 5 days. All experiments were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and the guidelines of Harvard Medical Area Standing Committee on Animals.
Blood Pressure
On day 19 of gestation, BP was measured via a PE-50 carotid arterial catheter connected to a pressure transducer.
Tissue Preparation
Rats were euthanized by CO 2 inhalation, the uterus was excised, and the litter size and individual pup weight were recorded. Third-order mesenteric arteries (≤300 μm OD) were dissected for measuring microvascular function, nitrate/nitrite production, and Western blots. The thoracic aorta was used for measuring nitrate/nitrite production and reverse transcription polymerase chain reaction (RT-PCR).
Measurement of Microvessel Diameter and [Ca

2+ ] i
Mesenteric microvessels were mounted between 2 glass cannulae (Living Systems Instrumentation, Burlington, VT), pressurized under 60 mm Hg, 20, 21 and the vessel diameter was measured using automatic edgedetection system. For measurement of [Ca 2+ ] i , microvessels were incubated in Krebs solution containing fura-2/AM (5 μmol/L) for 1 hour. 20, 21 Nitrate/Nitrite (NOx) Production Endothelium-intact aortic and mesenteric artery segments were treated with acetylcholine (ACh, 10 -6 mol/L), BQ-123+ET-1, sarafotoxin 6c (S6c), or IRL-1620 (10 -7 mol/L) for 30 minutes and the incubation solution was assayed for the stable end product of NO, NO 2 − using Griess reagent.
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Reverse Transcription Polymerase Chain Reaction
Total RNA was extracted from thoracic aorta using RNeasy Fibrous Tissue Mini Kit (QIAGEN, Valencia, CA), 1 μg total RNA was used for reverse transcription to synthesize single-strand cDNA, and 2 μL of cDNA dilution (1:5 for preproET, ET A R and ET B R, and 1:25 for α-actin) was applied to 20 μL RT-PCR reaction. Gene expression was measured using quantitative RT-PCR system (Mx4000, Stratagene, La Jolla, CA), published oligonucleotide primers for preproET, ET A R, and ET B R (Integrated DNA Technologies, Coralville, IA), and iQ-SYBR Green Supermix (Bio-Rad, Hercules, CA). Relative mRNA expression was calculated by the comparative ΔΔCT method, with α-actin as internal control.
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Western Blots
Microvessels were homogenized and proteins were separated by electrophoresis and transferred to nitrocellulose membranes. Membranes were probed with polyclonal anti-ET A R (sc-33536) or anti-ET B R antibody (sc-33538; 1:1000, Santa Cruz Biotechnology, Dallas, TX) at 4°C overnight. Immunoreactive bands were visualized using the ECL detection kit (GE Healthcare Bio-Sciences) and the intensity was normalized to β-actin.
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Immunohistochemisty
Transverse 6-μm-thick cryosections of mesenteric artery were labeled with polyclonal ET A R and ET B R antibodies (1:100). Vessel images were acquired on a Nikon microscope and analyzed using ImageJ (National Institutes of Health). The total wall thickness, relative thickness of the intima, media and adventitia, and the amount of ET A R and ET B R in the whole vessel wall and in each layer were measured.
Statistical Analysis
Experiments were conducted on vessels from n=4 to 12 rats per group. Data were presented as means±SEM. Concentration-dependent responses were fitted to sigmoidal curves using the least squares method and pD 2 (−log EC 50 ) was calculated using Graphpad Prism 5.01. Data were analyzed using repeated measures ANOVA and Bonferroni post hoc test for multiple comparisons or Student t test for comparison of 2 means. Differences were statistically significant when P<0.05.
Results
On gestation day 19, the mean arterial BP was greater in RUPP (130±3 mm Hg) than in Norm-Preg rats (92±6 mm Hg). RUPP rats showed smaller litter size (8±1 pups) and average pup weight (1.59±0.12 g) than Norm-Preg (13±1 pups, average weight 2.24±0.25 g).
In mesenteric microvessels of Norm-Preg ( Figure 1A ) and RUPP rats ( Figure 1B ), ET-1 (10 −7 mol/L) caused maintained decrease in diameter, associated with an initial peak followed by smaller increase in [Ca 2+ ] i ( Figure 1C Figure 1H ).
To test whether the enhanced vasoconstriction is specific to ET-1 or involves mechanisms shared by other vasoconstrictors, the α-adrenergic receptor agonist phenylephrine (10 −5 mol/L) caused significant decrease in microvessel diameter and an initial spike followed by smaller increase in [Ca 2+ ] i (Figure 2A -10 −5 mol/L) caused concentration-dependent constriction that was not different in vessels of RUPP (E max =56.3±3.9%; pD 2 =6.55±0.30) and Norm-Preg (E max =49.5±2.8%; pD 2 =6.59±0.33; Figure 2 ).
High KCI is known to cause membrane depolarization and to stimulate Ca 2+ entry. In microvessels of Norm-Preg ( Figure  2C ) and RUPP rats ( Figure 2D ] i in microvessels of Norm-Preg ( Figure 3E and 3G) but not RUPP ( Figure 3F and 3H), suggesting an intact vasodilator ET B R activity in NormPreg rats that is reduced in RUPP.
To test further the role of endothelium, in microvessels of Norm-Preg ( Figure 4A ) and RUPP ( Figure 4B ) preconstricted with phenylephrine, ACh caused concentration-dependent increases in diameter and simultaneous decreases in [Ca 2+ ] i . ACh was less potent in inducing relaxation in RUPP (pD 2 =6.06±0.10) than in Norm-Preg (pD 2 =6.91±0.12), with no differences in maximal relaxation (Figure 4) (Figure 4) . To test the responsiveness of VSM to vasodilators, the NO donor sodium nitroprusside caused concentration-dependent increases in diameter and decreases in [Ca 2+ ] I , and was equally potent in inducing relaxation in vessels of Norm-Preg (pD 2 =6.32±0.20; Figure 4C ) and RUPP rats (pD 2 =6.41±0.30; Figure 4D ) with no difference in maximal relaxation or underlying [Ca 2+ ] i (Figure 4) . In microvessels preconstricted with phenylephrine, ET-1 in the presence of the ET A R antagonist BQ-123 (10 −6 mol/L; Figure 5A ), or the selective ET B R agonists S6c ( Figure 5B ) and IRL-1620 ( Figure 5C ) caused concentration-dependent relaxation that was less in RUPP than in Norm-Preg, with no difference in [Ca 2+ ] i ( Figure 5D , 5E, and 5F). To investigate the vascular mediators released during microvascular relaxation, the NO synthase inhibitor Nω-nitro-L-arginine methyl ester (L-NAME) (3×10 −4 mol/L) plus cyclooxygenase inhibitor indomethacin (INDO, 10 −6 mol/L) caused a shift to the right in ACh concentration-relaxation curve in NormPreg (pD 2 control=6.91±0.12; +L-NAME+INDO=6.13±0.15; Figure 6A ), but not in RUPP (pD 2 control=6.06±0.10; +L-NAME+INDO=6.19±0.11; Figure 6B ), suggesting that an To test the vascular factors involved in ET B R-mediated relaxation, L-NAME+INDO reduced S6c-and IRL-1620-induced relaxation in microvessels of Norm-Preg ( Figure  6E and 6G), but not in RUPP ( Figure 6F and 6H). Additional treatment with tetraethylammonium or endothelium removal abolished S6c-and IRL-1620-induced relaxation in NormPreg ( Figure 6E and 6G) and RUPP ( Figure 6F and 6H). To test further the role of NO, we first measured nitrate/nitrite production in aortic segments as previously described. Using a similar protocol, nitrate/nitrite production was reduced in mesenteric arterial segments of RUPP versus Norm-Preg ( Figure 6J ).
RT-PCR revealed that preproET mRNA expression was greater and ET A R mRNA was not different, whereas ET B R mRNA was reduced in aorta of RUPP versus NormPreg ( Figure 7A ). Western blots revealed that ET A R protein level was not significantly different in endothelium-intact or -denuded microvessels of RUPP versus Norm-Preg, or between endothelium-denuded and intact microvessels of either RUPP or Norm-Preg ( Figure 7B) . ET B R level was insignificantly reduced (P=0.12) in endothelium-intact microvessels of RUPP versus Norm-Preg and significantly reduced in endothelium-denuded versus intact microvessels of both Norm-Preg and RUPP ( Figure 7C ). Interestingly, ET B R level was greater in endothelium-denuded microvessels of RUPP versus Norm-Preg ( Figure 7C ). To estimate the amount of endothelial ET A R and ET B R, the protein level in endotheliumdenuded vessels was subtracted from the protein level in endothelium-intact vessels. Although the estimated endothelial ET A R was not different ( Figure 7B ), the estimated endothelial ET B R was less in RUPP than in Norm-Preg ( Figure 7C ).
Immunohistochemistry revealed that total ET A R immunostaining was not different and total ET B R was insignificantly reduced (P=0.10) in mesenteric vessels of RUPP versus Norm-Preg ( Figure 7D and 7E). ET A R staining was not different in intima, media, or adventitia of RUPP versus Norm-Preg ( Figure 7F ). ET B R staining was significantly reduced in intima and endothelium, insignificantly increased in media, and not different in adventitia of mesenteric vessels of RUPP versus Norm-Preg ( Figure 7G ).
Infusion of ET B R antagonist BQ-788 for 5 days in NormPreg rats resulted in increased BP compared with control nontreated Norm-Preg ( Figure 8A mol/L)-induced concentration-dependent constriction ( Figure  8C ) were reduced in microvessels isolated from IRL-1620-infused versus nontreated RUPP. The relaxation response to ex vivo application of ET B R agonists S6c ( Figure 8E ) and IRL-1620 ( Figure 8F ) was also enhanced in microvessels of IRL-1620-infused versus nontreated RUPP.
Discussion
Preeclampsia is manifested as hypertension and often intrauterine growth restriction. 2, 23 Although the mechanisms of preeclampsia are unclear, placental ischemia is thought to be an initiating event. Studies in animal models of HTN-Preg such as the RUPP rat model of placental ischemia-induced hypertension have shown many of the features of preeclampsia. 4, 6, 8, 12 Consistent with these reports, the present study showed that RUPP in late pregnant rats was associated with increased BP, decreased litter size, and average pup weight. Studies have related the main characteristics of preeclampsia and HTN-Preg to generalized endotheliosis, 9 decreased release of vasodilator substances such as NO and EDHF, and increased release of vasoconstrictors such as ET-1. Plasma ET-1 levels are increased in preeclamptic women. 3, 11 Also, RUPP rats exhibit increased renal tissue expression of preproET. 13 Chronic hypoxia during pregnancy in rats is associated with preeclampsia-like manifestations and increased ET-1 plasma levels and preproET mRNA and ET A R protein in the kidneys and placenta. 24 Also, serum from RUPP rats increases ET-1 production by cultured endothelial cells. 17 Consistent with these reports, we found an increase in aortic preproET mRNA expression in RUPP versus Norm-Preg rats, supporting a role for enhanced ET-1 system in placental ischemia-induced hypertension.
To test the microvascular effects of ET-1 in HTN-Preg, ET-1-induced constriction was enhanced in RUPP versus Norm-Preg. These data are different from reports that ET-1 produces similar vascular contraction in Norm-Preg and RUPP rats. 19, 21 The differences may be related to regional differences along the arterial tree 25 (first-order mesenteric arteries 19 versus the present third-order mesenteric microvessels) or the method of measuring vascular function (wire myography 19 versus the present pressurized microvessels). Importantly, we observed enhanced ET-1 constriction in endothelium-intact but not -denuded vessels of RUPP versus Norm-Preg rats. Although we measured endothelium-dependent relaxation in our pressurized microvessels, other studies did not measure endothelial function, 19, 21 and the endothelium integrity could be compromised during microdissection or passage of wire in the vessel in the wire myography studies.
To test whether the enhanced contraction is specific to ET-1, the α-adrenergic receptor agonist phenylephrine caused ] i that were not different in microvessels of Norm-Preg and RUPP. The lack of difference in phenylephrine contraction is in accordance with other reports in mesenteric arteries, 21, 26 and suggests that the enhanced vasoconstriction in RUPP rats is specific to ET-1-activated receptor and signaling mechanisms and not generalized to receptor-mediated vasoconstrictor stimuli. To estimate endothelial ET A R and ET B R, the protein level in endothelium-denuded vessels was subtracted from that in endothelium-intact vessels (B and C, bottom). The distribution of ET A R and ET B R immunostaining was measured in vessel sections (D). Arrow indicates prominent staining in the intima. The total number of pixels in the tissue section was first defined, then the number of brown spots (pixels) was counted, and presented as % of total area (E). The number of pixels in the intima, media, and adventitia was also defined, then ET A R (F) and ET B R brown staining (G) was counted, and presented as % of the respective layer area. Data represent means±SEM (n=4-5 ] i but could also involve Ca 2+ sensitization pathways such as protein kinase-C, Rho-kinase, and mitogen-activated protein kinase. 29 Although ET-1 is known for its vasoconstrictor effects, intravenous injection of ET-1 causes transient hypotension followed by delayed increase in BP, 30, 31 which has been attributed to its 2 receptor subtypes, ET A R and ET B R. 32, 33 ET A R is largely localized in VSM causing vasoconstriction, increased [Ca 2+ ] i , and activation of other pathways of VSM contraction and growth. 34 In contrast, ET B R is located predominately in the endothelium and mediates vasodilation. 15, 35 Studies have shown that treatment of RUPP rats with an ET A R antagonist decreases BP, and suggested a role for ET A R in HTN-Preg. 13, 18, 24, 36 However, the decreased BP in RUPP rats treated with ET A R antagonist can also be explained by the possibility that most ET-1 would be directed toward endothelial ET B R to promote vasodilation, and thus made it important to examine the role of vascular ET B R in normotensive and HTN-Preg.
We have recently shown that upregulation of endothelial ET B R may be responsible for the blunted ET-1 vasoconstriction and enhanced ET B R-mediated vasodilation in Norm-Preg rats. 20 The present microvascular function studies suggest that the enhanced ET-1 constriction in HTN-Preg produced by RUPP could be as a result of downregulation of vasodilator endothelial ET B R because (1) endothelium removal enhanced ET-1 vasoconstriction and [Ca 2+ ] i in Norm-Preg but not in RUPP, suggesting that an endothelium-dependent pathway that reduces ET-1 contraction during Norm-Preg is compromised in RUPP rats. (2) Endothelium removal did not enhance phenylephrine contraction in microvessels of Norm-Preg or RUPP rats, supporting specific changes in ET-1 receptor/signaling in the endothelium. mRNA expression in aorta of RUPP versus Norm-Preg, (2) Western blots revealed that the estimated endothelial ET B R was less in microvessels of RUPP than of Norm-Preg, and (3) immunohistochemistry demonstrated prominent localization of ET B R in the mesenteric vessel intima of Norm-Preg that was reduced in RUPP rats. The observations that ET A R mRNA, protein level, and immunohistochemical distribution were not different in RUPP and Norm-Preg rats support that the enhanced ET-1 contraction in microvessels of RUPP rats is not because of primary increase in VSM ET A R and is more likely secondary to downregulation of endothelial ET B R vasodilator activity.
The endothelium releases NO, prostacyclin, and EDHF. NO diffuses into VSM where it increases cGMP, which causes vascular relaxation by decreasing VSM [Ca 2+ ] i and Ca 2+ sensitivity of contractile proteins. In agreement with studies of mesenteric arteries 26, 37 and aorta of RUPP rats, 12 ACh was less potent in inducing relaxation and decreasing [Ca 2+ ] i in microvessels of RUPP than of Norm-Preg rats. Similar to ACh, the decreased ET B R-mediated relaxation in RUPP rats is partly as a result of decreased endothelium-derived NO and the NO-cGMP relaxation pathway because (1) ] i were not different in microvessels of RUPP and Norm-Preg rats, supporting that the impaired AChand ET B R agonists-induced relaxation was not because of decreased sensitivity of VSM to NO-cGMP. (5) While EDHF is an important vasodilator in resistance arteries 38 and may explain the L-NAME+INDO-resistant component of ACh-, S6c-, and IRL-1620-induced relaxation, its blockade with tetraethylammonium caused similar inhibition of ACh-and ET B R-agonist-induced relaxation in RUPP and Norm-Preg rats, supporting an intact EDHF and equally active EDHFdependent ET B R-mediated pathway in both groups. The reduced ET B R-mediated NO but not EDHF pathway in RUPP rats could be related to possible uncoupling of ET B R from NO but not EDHF, or the presence of sub-population of ET B R or other ET-1 receptor subtype(s) with different post-receptor NO or EDHF signaling through receptor heterodimerization or cross-talk mechanisms.
Our in vivo findings also support a role of ET B R downregulation in HTN-Preg. Infusion of ET B R antagonist BQ-788 in pregnant rats caused an increase in BP, likely because during ET B R blockade most of endogenous ET-1 will bind to ET A R and cause vasoconstriction. ET B R is also involved in ET-1 clearance, and ET B R blockade is predicted to allow more endogenous ET-1 to activate ET A R and increase vasoconstriction and BP. 35 A study by Madsen et al 39 showed that infusion of ET B R antagonist A-192621 caused maintained increases in BP in virgin rats and dose-dependently increased maternal BP, although these increases were not sustained in pregnant rats. Although we observed comparable elevation in maternal BP, the cause of the differences in maintained BP is unclear and could be partly related to the ET B R antagonist used (ie, A-19261 versus BQ-788). Also, BP regulation involves not only vascular but also renal, neuronal, and hormonal mechanisms, and increased BP via the vascular mechanism could be compensated for by other control mechanisms. For instance, ET B R in the renal medulla may regulate salt and water excretion, plasma volume, and BP. 33 Also, changes in vascular reactivity in vivo may be compensated for by cardiac baroreceptor reflexes and mask any vascular effects on BP. 25 We should note that the Madsen study 39 did not measure vascular function, whereas we measured the direct ex vivo effects of ET B R agonists and antagonists on microvessels and demonstrated a role of decreased endothelial ET B R in the decreased vasodilation in HTN-Preg. Furthermore, we showed that infusion of ET B R agonist IRL-1620 reduced BP in RUPP rats and that ET-1 constriction and [Ca 2+ ] i were reduced, and S6c-and IRL-1620-induced relaxation were enhanced in microvessels of RUPP rats infused with IRL-1620, supporting that increasing ET B R activity improves ET B R-mediated vasodilation, reduces vasoconstriction, and decreases BP in HTN-Preg. Whether the effects of in vivo modulation of ET B R using ET B R agonists and antagonists on BP and microvascular activity reflect changes in the sensitivity, mRNA expression, protein levels, vascular tissue localization of ET B R, or all of the items listed should be examined in future studies.
An important question is what causes downregulation of endothelial ET B R in HTN-Preg. Preeclampsia and HTN-Preg are associated with increased vasoactive factors such as cytokines, anti-angiogenic factors, and angiotensin receptor type-1 agonistic auto-antibody. [6] [7] [8] 36 Serum tumor necrosis factor-α is increased in RUPP rats, 36 and infusion of pregnant rats with tumor necrosis factor-α is associated with decreased vascular relaxation, increased contraction, HTN-Preg, 7 and increased preproET mRNA expression in the placenta, aorta, and kidneys. 36 Also, in preeclampsia there is an imbalance between the angiogenic factors vascular endothelial growth factor and placental growth factor, and the anti-angiogenic factor soluble fms-like tyrosine kinase-1.
9 RUPP rats also show increased serum soluble fms-like tyrosine kinase-1, 8 and infusion of soluble fms-like tyrosine kinase-1 in pregnant rats results in increased BP, decreased plasma vascular endothelial growth factor, 40 and increased tissue levels of ET-1. 41 In preeclampsia, there is also an increase in angiotensin receptor type-1 agonistic auto-antibody, which could activate angiotensin type-1 receptor in VSM leading to enhanced vasoconstriction and HTN-Preg, 6, 42 and infusion of angiotensin receptor type-1 agonistic auto-antibody in pregnant rats causes increases in renal and placental ET-1. 6 Future studies should test whether the vasoactive factors released during HTN-Preg affect the expression/activity of endothelial ET B R. ET B R has been identified not only in endothelium, but may also be expressed in VSM, where it could promote vasoconstriction. 15, 22, 43 Our Western blots showed greater ET B R levels in endothelium-denuded microvessels and immunohistochemistry showed insignificant increase (P=0.10) in ET B R in tunica media of mesenteric vessels of RUPP versus Norm-Preg rats, suggesting a role of VSM ET B R in hypertension-Preg, and the functionality and potential vasoconstrictive effects of these receptors need to be further evaluated in endothelium-denuded vessels and isolated VSM cells.
Perspectives
Endothelial ET B R expression/activity is reduced in pregnant rats with RUPP and may explain the increased BP and ET-1 vasoconstriction and reduced ET B R-mediated relaxation in placental ischemia-induced hypertension. Although the data should be interpreted in a more circumspect fashion because there are forms of HTN-Preg and preeclampsia that may not be adequately represented by the RUPP model, the results suggest that ET B R could be an important target in HTN-Preg, and upregulation of endothelial ET B R, using pharmacological agonists or genetic manipulation, may represent a novel approach in managing preeclampsia. Time-pregnant (day 11) Sprague-Dawley rats (12 week of age) were purchased from Charles River Laboratories (Wilmington, MA). The rats were housed in the animal facility and maintained on ad libitum standard rat chow and tap water in 12-hr light-dark cycle. On day 13 of pregnancy, rats were either sham-operated (Norm-Preg) or underwent surgical procedure to reduce uteroplacental perfusion pressure (RUPP) by placing a silver clip (0.203 mm ID) on lower abdominal aorta above iliac bifurcation and two clips (0.1 mm ID) on uterine branches of the ovarian artery. [1] [2] [3] This procedure reduces uterine perfusion pressure in the gravid rat by ∼40%. 4 While the timing of surgery was slightly earlier, these procedures produced comparable results to those reported in Sprague-Dawley rats from either Charles River Laboratories 2, 5, 6 or Harlan Inc (Indianapolis, IN) 1,3 when the RUPP surgery was performed on day 14 of pregnancy and blood pressure measured on day 19. However, the timing of surgery in relation to the actual date of measurement of blood pressure and other maternal and fetal parameters is important and could have potential implications as other studies showed that when the RUPP surgery was performed on day 12 and blood pressure measured on day 17 a milder form of hypertension was observed. 6 RUPP rats in which the clipping procedure resulted in maternal death or total reabsorption of the fetuses were excluded from the data analyses.
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Downregulation of Microvascular Endothelial
To test the role of ET B R in HTN-Preg, a separate group of pregnant rats (day 14) were infused with the ET B R antagonist BQ-788 100 µg/kg/day subcutaneously for 5 days using osmotic minipump. Also, some of the RUPP rats were infused with the ET B R agonist IRL-1620 100 µg/kg/day subcutaneously for 5 days using osmotic minipump. 7 All surgical procedures were performed using aseptic technique and proper anesthetics and analgesics in accordance with the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals, and the guidelines of the Harvard Medical Area Standing Committee on Animals.
Measurement of Arterial Pressure
On day 19 of pregnancy, rats were anaesthetized with isoflurane, a PE-50 catheter was inserted in the carotid artery, and exteriorized at the back of the neck. The rats were allowed to recover from anesthesia for at least 1 hr. The carotid arterial catheter was connected to a pressure transducer attached to an amplifier and blood pressure (BP) recorder (Living System Instrumentation, Burlington, VT), BP in conscious rats was recorded every 20 min for 1 hr and the average mean arterial BP was measured.
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Tissue Preparation
After measuring BP, rats were euthanized by inhalation of CO 2 , the uterus was excised, and the litter size and individual pup weight were recorded. Also, the mesentery and mesenteric arterial arcade were rapidly excised and placed in ice-cold oxygenated Krebs physiological solution. With the aid of a dissection microscope, small third order mesenteric microvessels outside diameter (OD) 300 m were carefully isolated and cleaned of fat and adipose tissue and used for microvascular functional studies. Similar size microvessels have been considered as resistance arteries in other studies 10 and have been reported to contribute to peripheral vascular resistance in conscious rats 11 and to show pregnancy-associated alterations in reactivity. 2 Attempts were made to dissect the microvessels as close as possible to the wall of the gut with the aim of isolating at least a 4-5 mm-long complete vessel segment, specifically avoiding injuring or having any branches or holes in the microvessel, which would interfere with the vessel pressurization. The remainder of mesenteric vessels were used to measure nitrate/nitrite production or stored at -80°C for Western blots. The thoracic aorta was also excised for measurement of nitrate/nitrite production and RT-PCR.
Microvessel Cannulation and Pressurization
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Mesenteric microvessels ~4-5 mm in length were transferred to a 5 ml temperaturecontrolled perfusion chamber, mounted between two glass micropipettes (cannulas), and secured with 10-0 ophthalmic nylon monofilament (Living Systems Instrumentation) as previously described. 5, 12 One end of the microvessel was mounted on the first glass micropipette and the lumen was gently rinsed with Krebs solution to remove any remaining blood, then the other end of the microvessel was mounted on the second cannula and tied in place. The microvessel segment in the perfusion chamber was placed on an inverted microscope (TE300, Nikon, Melville, NY). A stopcock located distal to the vessel was closed, the proximal end was connected to a pressure transducer and pressure servo control system (Living Systems Instrumentation). The microvessel was pressurized under 60 mmHg and maintained at constant pressure using the pressure-servo control unit. 5, 12 The microvessel was bathed in 5 ml of Krebs bubbled with 95% O 2 and 5% CO 2 at 37°C and was continuously superfused with fresh Krebs at a rate of 1 ml/min using a peristaltic mini-pump (Master-Flex; Cole-Parmer, Vernon Hills, IL). The microvessel was allowed to equilibrate for 60 min before testing its functional viability using high potassium chloride (KCl) depolarizing solution (51 mM), phenylephrine (Phe, 10 -5 M) and acetylcholine (ACh 10 -5 M). Microvessels were unacceptable if they showed leaks or if they failed to produce maintained constriction to KCl and Phe or dilation to ACh.
The mesenteric microvessels were continuously monitored using a video camera connected to a monitor, and the microvessel diameter was measured using automatic edgedetection system (Crescent Electronics, Sandy, UT) and digitized at 1 Hz using a personal computer as previously described. 5, 12 Snap-pictures of the microvessel were taken at rest and following steady-state constriction to different vasoconstrictor stimuli using a digital camera (Cool-Snap, Photometrics, Tucson, AZ).
Fura-2 Loading and [Ca
2+
] i Recording For measurement of intracellular free Ca 2+ concentration ([Ca   2+ ] i ), microvessels were incubated in Krebs solution containing the cell permeable Ca 2+ indicator fura-2/AM (5 M) and the mild detergent cremophor EL (0.25%) for 1 hr as previously described. 5, 12 The microvessel was washed 3 times in Krebs to remove extracellular fura-2/AM and incubated in normal Krebs for an additional 30 min to allow for de-esterification of the trapped intracellular fura-2/AM into the Ca 2+ -sensitive fura-2. The fura-2-loaded microvessel was excited alternately at 340 and 380 nm, and the emitted light was collected at 510 nm every 1 sec and the fluorescence signal was measured using Felix Fluorescence data acquisition and analysis software (Photon Technology International, Birmingham, NJ). The 340/380 ratio was calculated and represented the changes in [Ca 2+ ] i . The signal-to-noise ratio was improved by averaging 10 consecutive 340/380 fluorescence ratio readings.
Simultaneous Measurement of Microvessel Diameter and [Ca
2+
] i In all experiments, the microvessel from Norm-Preg or RUPP rats was first stimulated with 51 mM KCI and the simultaneous changes in constriction and 340/380 ratio (indicative of [Ca 2+ ] i ) were recorded. Our initial experiments demonstrated that KCl-and Phe-induced changes in [Ca 2+ ] i were rather small. Also, the ET-1 response was relatively slow in onset, particularly at low concentrations, and a cumulative-constriction response curve would require prolonged exposure to excitation light, which would cause significant photobleaching of fura-2 and affect the accuracy of [Ca 2+ ] i measurements. Therefore, to accurately compare the [Ca 2+ ] i -dependent constriction induced by various agonists, we used maximal agonist concentration and an 8-min exposure time. The maximal concentrations of ET-1 (10 -7 M), Phe (10 -5 M) and KCl (51 mM) used were based on previous reports from our laboratory. 5, 12 To measure the effects of ET-1, M) and KCI (16 to 96 mM) were also measured. We should note that the plasma ET-1 levels are in the range of 3 to 12 pmol/L in Norm-Preg women and 6 to 23 pmol/L in preeclamptic women. 13, 14 However, the endogenous ET-1 released from the endothelium mainly functions as an autocrine or paracrine factor on the ET b R and ET A R receptors on the adjacent endothelial and VSM cells. Because ET-1 secretion is directional, with a larger proportion of the peptide being released on the basolateral side of the endothelium, ET-1 levels in the circulation may not accurately reflect the tissue levels of ET-1. 15, 16 To block ET B R-mediated relaxation, in some experiments, microvessels were pretreated with the ET B R antagonist BQ-788 (10 -6 To elucidate the vasodilator mediator released during stimulation by ACh, S6c and IRL-1620 concentration-relaxation curves were repeated in the presence of N ω -nitro-L-arginine methyl ester (L-NAME, 310 -4 M) to block nitric oxide synthase (NOS) and indomethacin (INDO, 10 -6 M) to block cyclooxygenase (COX). Previous studies have shown minimal contribution of PGI 2 to vasodilation in rat mesenteric arteries. 17 Therefore, in all experiments, both NOS and COX activity were blocked simultaneously. To test for a hyperpolarization pathway, experiments were repeated in the presence of tetraethylammonium chloride (TEA, 30 mM), a non-selective K + channel blocker.
To confirm the role of endothelium, in some experiments the endothelium was removed by gently injecting air bubbles through the microvessels while still mounted in the arterial chamber (total volume of injected air bubbles ~0.3 ml). Endothelium removal was determined by the absence of vasodilator responses (<10%) to ACh (10 -5 M) , and the integrity of VSM function was confirmed by the maintenance of the constrictor response to Phe (10 -5 M). To directly test the ability of VSM to relax, microvessels were preconstricted with Phe (610 -6 M), then stimulated with increasing concentrations of the exogenous NO donor sodium nitroprusside (SNP, 10 
Nitrate/Nitrite (NOx) Measurement
Endothelium-intact thoracic aorta or mesenteric artery segments were placed in 2 ml Krebs solution aerated with 95% O 2 5% CO 2 at 37°C for 30 min, and samples for basal accumulation of nitrite (NO 2 -) formed from released NO were taken. Vascular segments were treated with ACh (10 -6 M), BQ-123+ET-1 (10 -7 M), S6c (10 -7 M) or IRL-1620 (10 -7 M) for 30 min, then rapidly removed, dabbed dry with filter paper and weighed. The incubation solutions were assayed for the stable end product of NO, NO 2 -. Samples of incubation solution (50 l, in triplicate) were mixed in 96-well microplate with 100 l Griess reagent. The chromophore generated from the reaction with NO 2 -was detected spectrophotometrically (535 nm) using SpectraMAX microplate reader (Molecular Devices, Sunnyvale CA). The concentration of NO 2 -was calculated using a calibration curve with known concentrations of NaNO 2 .
1
Real-Time RT-PCR Analysis
We could not measure mRNA in mesenteric microvessels, and therefore used the thoracic aorta for RT-PCR analysis. Because Western blots require large amount of protein, we dissected the whole mesenteric arterial arcade in order to collect sufficient tissue from each animal for the protein analysis. Also, in order to delineate endothelial vs. VSM ET B R, we divided the mesenteric vessels into endothelium-intact and -denuded mesenteric vessels. Because of the intricate mesenteric arterial tree, the dissection of mesenteric arteries from adipose tissue and adjacent veins is somewhat tedious and takes a long time and therefore could interfere with the integrity of the rapidly degrading mRNA. Because the aorta is easier to isolate and dissect, we opted to use the aorta to rapidly collect sufficient tissue with intact RNA for the mRNA measurements. Total RNA was extracted from thoracic aorta using RNeasy 5'-GTTAGCAAGGTCGGATGCTC -3' PCR was carried out with 1 cycle for 10 min at 95°C then 40-45 cycles of 30 sec denaturation at 95°C, 45 sec of annealing at 56°C, and 30 sec of extension at 72°C, followed by 1 min of final extension step at 95°C. The number of PCR cycles varies according to the expression level of the target gene. An appropriate primer concentration and number of cycles was determined to ensure that the PCR is taking place in the linear range and thereby guarantees a proportional relationship between input RNA and the cycles readout. Relative quantification of gene expression was performed by the comparative CT (CT) method with -actin as endogenous control as previously described.
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Western Blot Analysis
Three samples of endothelium-intact mesenteric arteries were prepared; each sample containing arteries pooled from 4 rats per group. In other samples, the endothelium was removed by passing air bubbles through the lumen of the artery while mounted in the arterial chamber or by pinning down the excised mesenteric arteries in a petri dish, inserting a thin wire (~150 m ID) into the vessel lumen and carefully rubbing the vessel interior three times 7
Immunohistochemisty
To determine the tissue distribution of ET receptor subtypes transverse cyrosections (6 μm in thickness) were prepared from OCT embedded mesenteric artery of Norm-Preg and RUPP rats. Immediately before immunostaining, cyrosections were thawed and fixed in ice-cold acetone for 10 min and rehydrated in phosphate buffered saline (PBS) containing 0.25% triton X-100 for 15 min at room temperature. Endogenous peroxidase activity was quenched with 1.5% H 2 O 2 (Sigma) in methanol (Sigma) for 10 min, and nonspecific binding was blocked in 10% horse serum (VectaStain Elite ABC Kit, Vector Laboratories, Burlingame, CA) in PBS for 30 min. Tissue sections were incubated with rabbit polyclonal ET A R or ET B R primary antibody (1:100, Santa Cruz Biotechnology) for 1 hr then washed with PBS. Tissue sections were then incubated with biotinylated anti-rabbit secondary antibody for 30 min, rinsed with PBS, then incubated with avidin-labeled peroxidase (VectaStain Elite ABC Kit) for 30 min, followed by a rinse in PBS for 5 min. Positive labeling was visualized using diaminobenzadine (DAB) and appeared as brown spots. Negative control slides were run simultaneously with no primary antibody, and showed no detectable immunostaining. Sections were counterstained with Gills hematoxylin for 30 sec and cover slipped with cytoseal 60 mounting medium (8310; RichardAllen Scientific, Kalamazoo, MI). Images of tissue sections were acquired on a Nikon microscope with digital camera mount using the same magnification, light intensity, exposure time and camera gain, and the images were analyzed using ImageJ software (NIH).
Total ET A R or ET B R content (visualized as brown spots) was quantified using bright-field illumination and images were background subtracted using ImageJ software. For quantification of ET A R and ET B R immunostaining, the total number of pixels in the tissue section image was first defined, then the number of brown spots (pixels) was counted and presented as % of total area. The number of pixels in the specific vascular layer (intima, media and adventitia) was also defined, then the ET A R or ET B R brown immunostaining was counted and presented as percentage of the respective layer area.
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Solution and Drugs
Krebs solution contained in mM 120 NaCl, 5.9 KCl, 25 NaHCO 3 , 1.2 NaH 2 PO 4 , 11.5 dextrose, 2.5 CaCl 2 , 1.2 MgCl 2 , at pH 7.4, and bubbled with 95% O 2 and 5% CO 2 . High KCl (51 mM) solution was prepared as Krebs solution with equimolar substitution of NaCl with KCl. Stock solutions of Phe, ACh, SNP, ET-1, L-NAME (10 −1 M; Sigma-Aldrich), S6c and IRL-1620 (10 -3 M; Tocris Bioscience, llsville, MO) were prepared in distilled water. TEA (30 mM, Sigma) was prepared as Krebs solution with equimolar substitution of NaCl with TEA. Stock solution of indomethacin (INDO, 10 −2 M; Sigma), the ET A R antagonist BQ-123, the ET B R antagonist BQ-788 (10 -3 M; Tocris Bioscience), and the Ca 2+ indicator fura-2/AM (10 -3 M, Invitrogen, Carlsbad, CA) were prepared in DMSO. Further dilutions of BQ-123 or BQ-788 were made either in saline (for in vivo infusion) or in distilled water (for ex vivo experiments). The final concentration of DMSO in the experimental solution was <0.1%. All other chemicals were of reagent grade or better.
Statistical Analysis
Experiments were conducted on mesenteric vessels isolated from 4-12 different rats per group, and cumulative data were presented as means±SEM, with the "n" value representing the number of rats per group. Time-dependent constriction was measured as: [(resting diameterconstriction diameter) / resting diameter] Χ 100. Time-dependent relaxation was measured as [(relaxation diameter -Phe preconstriction diameter) / (resting diameter -Phe preconstriction diameter)] Χ 100. Concentration-dependent contraction and relaxation were expressed as percentage of maximum response of the specific agonist, concentration-response curves were constructed, sigmoidal curves were fitted to the data using the least squares method, and the
